For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240605:nRSE1272Ra&default-theme=true
RNS Number : 1272R GlobalData PLC 05 June 2024
05 June 2024
GlobalData Plc
(AIM: DATA, GlobalData, the Group)
Investment in Healthcare Division by Inflexion
Investment agreement with Inflexion for a minority stake in GlobalData's
Healthcare division
Further to the announcement made on 21 December 2023 regarding the proposed
investment by Inflexion Private Equity Partners LLP into GlobalData's
Healthcare division, the Company is pleased to announce that all the
regulatory and other conditions have now been satisfied and that completion of
the investment will take place on 28 June 2024. On completion, the Company
will receive net cash proceeds of approximately £434 million.
Mike Danson, CEO of GlobalData, commented: "This investment in our Healthcare
division represents a compelling crystallisation of the significant value that
has been created for our shareholders through the delivery of our growth
strategy. We are delighted to be partnering with Inflexion to take our
Healthcare division into its next phase of growth.
Our business will continue to evolve rapidly through our 2024-2026 Growth
Transformation Plan, as we invest in products and AI and leverage the proceeds
from this transaction to accelerate growth investment and targeted M&A
across the Group."
ENDS
ENQUIRIES
GlobalData Plc
Mike Danson, Chief Executive Officer 0207 936 6400
Graham Lilley, Chief Financial Officer
J.P. Morgan Cazenove (Nomad, Joint Broker) 0203 493 8000
Bill Hutchings
Mose Adigun
Alex Bruce
Panmure Gordon (Joint Broker) 0207 886 2500
Rupert Dearden
Dougie McLeod
Investec Bank plc (Joint Broker) 0207 597 5970
Henry Reast
Virginia Bull
FTI Consulting (Financial PR) 0203 727 1000
Edward Bridges
Dwight Burden
Emma Hall
J.P. Morgan Cazenove is acting as Sole Financial Advisor to GlobalData
Plc. Reed Smith LLP is acting as legal counsel to GlobalData.
J.P. Morgan Securities plc, which conducts its UK investment banking
activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), and which is
authorised in the United Kingdom by the Prudential Regulation Authority and
regulated in the United Kingdom by the Financial Conduct Authority and
the Prudential Regulation Authority, is acting exclusively as sole financial
adviser for GlobalData Plc and no one else in connection with the
Transaction and shall not be responsible to anyone other than GlobalData
Plc for providing the protections afforded to clients of J.P. Morgan Cazenove
or its affiliates, nor for providing advice in connection with the Transaction
or any other matter referred to herein
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDFIMBTMTMMTPI